搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Cronobacter sakazakii Lipid A palmitoyltransferase PagP (pagP) CSB-YP415733CXL
CSB-EP415733CXL
CSB-BP415733CXL
CSB-MP415733CXL
CSB-EP415733CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii N-succinylglutamate 5-semialdehyde dehydrogenase (astD) CSB-YP415734CXL
CSB-EP415734CXL
CSB-BP415734CXL
CSB-MP415734CXL
CSB-EP415734CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Probable manganese transport protein MntH (mntH), partial CSB-YP415735CXL
CSB-EP415735CXL
CSB-BP415735CXL
CSB-MP415735CXL
CSB-EP415735CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP415736CXL
CSB-EP415736CXL
CSB-BP415736CXL
CSB-MP415736CXL
CSB-EP415736CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Ribosomal RNA small subunit methyltransferase B (rsmB) CSB-YP415737CXL
CSB-EP415737CXL
CSB-BP415737CXL
CSB-MP415737CXL
CSB-EP415737CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii 30S ribosomal protein S17 (rpsQ) CSB-YP415738CXL
CSB-EP415738CXL
CSB-BP415738CXL
CSB-MP415738CXL
CSB-EP415738CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii 30S ribosomal protein S10 (rpsJ) CSB-YP415739CXL
CSB-EP415739CXL
CSB-BP415739CXL
CSB-MP415739CXL
CSB-EP415739CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii 4-hydroxybenzoate octaprenyltransferase (ubiA), partial CSB-YP415740CXL1
CSB-EP415740CXL1
CSB-BP415740CXL1
CSB-MP415740CXL1
CSB-EP415740CXL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP415741CXL
CSB-EP415741CXL
CSB-BP415741CXL
CSB-MP415741CXL
CSB-EP415741CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP415742CXL
CSB-EP415742CXL
CSB-BP415742CXL
CSB-MP415742CXL
CSB-EP415742CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii ATP-dependent RNA helicase rhlB (rhlB) CSB-YP415743CXL
CSB-EP415743CXL
CSB-BP415743CXL
CSB-MP415743CXL
CSB-EP415743CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Diaminopimelate epimerase (dapF) CSB-YP415744CXL
CSB-EP415744CXL
CSB-BP415744CXL
CSB-MP415744CXL
CSB-EP415744CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii 50S ribosomal protein L11 (rplK) CSB-YP415745CXL
CSB-EP415745CXL
CSB-BP415745CXL
CSB-MP415745CXL
CSB-EP415745CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB CSB-YP415746CXL
CSB-EP415746CXL
CSB-BP415746CXL
CSB-MP415746CXL
CSB-EP415746CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Potassium-transporting ATPase C chain (kdpC), partial CSB-YP415747CXL1
CSB-EP415747CXL1
CSB-BP415747CXL1
CSB-MP415747CXL1
CSB-EP415747CXL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Enolase (eno) CSB-YP415748CXL
CSB-EP415748CXL
CSB-BP415748CXL
CSB-MP415748CXL
CSB-EP415748CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Lysophospholipid transporter lplT (lplT), partial CSB-YP415749CXL
CSB-EP415749CXL
CSB-BP415749CXL
CSB-MP415749CXL
CSB-EP415749CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio harveyi Tryptophan synthase beta chain (trpB) CSB-YP415750VEA
CSB-EP415750VEA
CSB-BP415750VEA
CSB-MP415750VEA
CSB-EP415750VEA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio harveyi UPF0115 protein VIBHAR_03116 (VIBHAR_03116) CSB-YP415751VEA
CSB-EP415751VEA
CSB-BP415751VEA
CSB-MP415751VEA
CSB-EP415751VEA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio harveyi ADP-L-glycero-D-manno-heptose-6-epimerase (hldD) CSB-YP415752VEA
CSB-EP415752VEA
CSB-BP415752VEA
CSB-MP415752VEA
CSB-EP415752VEA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>